Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Employment agrmnt Director departure Appointed director
|
UNIGENE LABORATORIES INC (UGNE)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/02/2013 |
8-K
| Resignation/termination of a director |
06/17/2013 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs:
|
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities Intermediate Fund, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Intermediate Fund II (Cayman), L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Fund II, L.P" |
|
06/13/2013 |
SC 13D/A
| Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC. |
06/07/2013 |
8-K
| Quarterly results |
05/29/2013 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
05/24/2013 |
SC 13D/A
| Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC. |
05/14/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
05/02/2013 |
SC 13D/A
| Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC. |
04/30/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
04/22/2013 |
D
| Form D - Notice of Exempt Offering of Securities |
04/16/2013 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
04/12/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/12/2013 |
8-K
| Form 8-K - Current report |
03/15/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
03/12/2013 |
8-K
| Quarterly results
Docs:
|
"UNIGENE LABORATORIES, INC. BALANCE SHEETS DECEMBER 31, 2012 and 2011 2012 2011 ASSETS Current Assets: Cash and cash equivalents $ 3,813,492 $ 4,681,683 Accounts receivable 76,255 2,854,038 Accounts receivable - Tarsa -- 8,193 Inventory, net 898,042 1,283,550 Due from former China joint venture partner -- 600,000 Prepaid expenses and other current assets 848,573 862,761 Total Current Assets 5,636,362 10,290,225 Noncurrent inventory, net 1,063,633 1,946,647 Property, plant and equipment, net 2,651,819 2,977,058 Patents and other intangibles, net 1,920,574 2,020,458 Deferred financing costs, net -- 619,767 Other assets 40,513 341,014 Total Assets $ 11,312,901 $ 18,195,169 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable $ 731,359 $ 1,472,925 Accrued expenses 2,244,8..." |
|
03/06/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
01/31/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
01/31/2013 |
10-Q/A
| Quarterly Report for the period ended June 30, 2012 [amend] |
01/31/2013 |
10-Q/A
| Quarterly Report for the period ended March 31, 2012 [amend] |
01/31/2013 |
10-K/A
| Annual Report for the period ended December 31, 2011 [amend] |
12/21/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
12/21/2012 |
8-K
| Other Events |
12/19/2012 |
8-K
| Other Events |
11/27/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
11/23/2012 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
11/21/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
11/09/2012 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
10/19/2012 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
10/16/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
10/04/2012 |
SC 13D/A
| Victory Park Capital Advisors, LLC reports a 65.3% stake in UNIGENE LABORATORIES, INC. |
10/03/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/26/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"Second Amendment to Rights Agreement",
"Forbearance Agreement and First Amendment to Amended and Restated Financing Agreement, by and among the Company, the Lenders and Victory Park Management, LLC, as agent",
"Senior Secured Convertible Note, reissued by Company as of September 24, 2012 in favor of VPC Intermediate Fund II (Cayman), L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of VPC Fund II, L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of Victory Park Credit Opportunities Intermediate Fund, L.P",
"Senior Secured Convertible Note, reissued by the Company as of September 24, 2012 in favor of Victory Park Credit Opportunities, L.P",
"Senior Secured Convertible Note, issued by the Company as of September 21, 2012 in favor of VPC Fund II, L.P",
"Second Amended and Restated Registration Rights Agreement, by and among the Company and the Lenders",
"Indemnification Agreement between the Company and Richard N. Levy",
"Patent Security Agreement, by the Company in favor of Victory Park Management, LLC, as agent" |
|
09/19/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
09/07/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|
|